Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.
BMC Cancer. 2014 Aug 7;14:570. doi: 10.1186/1471-2407-14-570.
BMC Cancer. 2014.
PMID: 25104095
Free PMC article.